Range Financial Group’s Trueblue TBI Stock Holding History

Range Financial Group’s Portfolio TBI Stock Details TBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-15,219	Closed	-$428K	–	184
2021 Q2	$428K	Buy	+15,219	New	+$405K	0.32%	104

Other funds holding TBI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Range Financial Group's TBI Position: Q3 2021 in Review

Range Financial Group sold out of Trueblue (TBI) in Q3 2021, closing a stake of 15,219 shares — an estimated $428K sold.

Range Financial Group first reported a position in TBI in Q2 2021 and held it in 1 quarter. The position peaked at $428K in Q2 2021. 170 funds tracked by Wall St. Rank hold TBI as of Q3 2021.

Range Financial Group reported no remaining Trueblue position as of Q3 2021 after selling out during the quarter.
Range Financial Group sold 15,219 Trueblue shares in Q3 2021, an estimated $428K.
Range Financial Group first reported a position in Trueblue in Q2 2021 and held it in 1 quarter.
Range Financial Group's Trueblue position peaked at $428K in Q2 2021.
170 funds tracked by Wall St. Rank held Trueblue as of Q3 2021.

Based on Range Financial Group's 13F filing for Q3 2021, filed 11 Jul 2022.